Pharmacodynamics and clinical use of phenobarbital
Phenobarbital (Phenobarbitalum) is classified as a long-acting barbiturate. The drug exhibits pronounced antiepileptic, hypnotic, and sedative effects.
In modern clinical practice, its use is strictly differentiated:
- Antiepileptic agent: this is the primary and most justified indication for prescribing phenobarbital.
- Hypnotic agent: in this capacity, the drug is used very sparingly due to pronounced adverse effects.
- Sedative agent: phenobarbital is frequently used in small doses as part of well-known combination drugs (e.g., Valocordin drops), where it provides a calming effect.
Pharmacokinetics and effects on the liver
A distinctive feature of phenobarbital is its slow elimination from the body. The clinical effect after administration lasts about 8 hours, but delayed elimination creates a high risk of accumulation—a dangerous buildup of the active substance in the body with regular intake.
A critically important aspect of phenobarbital pharmacokinetics is its effect on the hepatobiliary system. It acts as a potent inducer of hepatic microsomal enzymes. This leads to two major consequences:
- The metabolism of other concurrently administered medications is accelerated, which may reduce their efficacy.
- The phenomenon of autoinduction occurs—the drug accelerates its own metabolism with chronic use.
Adverse effects of barbiturates
The use of phenobarbital is associated with a number of serious adverse reactions. Like all members of the barbiturate group, it severely disrupts the physiological sleep architecture.
Particular attention should be paid to the hangover effect (residual effect). The morning after taking the drug, the patient does not feel rested; on the contrary, the following are observed:
- General depression of the nervous system and drowsiness.
- A feeling of severe "malaise" or grogginess.
- Various motor disorders.
In addition, systemic reactions are possible, including arterial hypotension and allergic manifestations (such as skin rashes). With repeated and prolonged use, tolerance (habituation requiring dose escalation) and severe drug dependence inevitably develop.
Characteristics of cyclobarbital
Cyclobarbital is a short- or intermediate-acting barbiturate. Its clinical effect lasts approximately 5–6 hours, and the elimination half-life ($t_{1/2}$) ranges from 20 to 25 hours.
Compared to phenobarbital, cyclobarbital has an important advantage: the hangover effect is significantly less pronounced. Historically, this drug was widely used in medicine prior to the advent of safer benzodiazepines. Today, it is rarely used in pure form, but it finds modern application as part of the combination hypnotic drug Reladorm, where its action is complemented by the tranquilizer diazepam.
Briefly: answers to topical questions
What is the molecular mechanism of action of phenobarbital?
The molecular mechanism of action of phenobarbital involves interaction with barbiturate binding sites located on the macromolecular $\text{GABA}_\text{A}$-receptor–chloride channel complex. This binding produces the following effects:
- Increased sensitivity of the $\text{GABA}_\text{A}$ receptor to the inhibitory neurotransmitter (GABA).
- Prolongation of the opening time of chloride channels.
- Massive influx of chloride ions into the cell, which triggers membrane hyperpolarization and enhances inhibitory processes.
Additionally, the drug exhibits direct GABA-mimetic activity and acts as an antagonist of excitatory neurotransmitters (inhibiting the action of glutamate).
What are the absolute contraindications to the use of phenobarbital?
Absolute contraindications to the use of phenobarbital include:
- pregnancy and lactation;
- severe hepatic and renal diseases;
- myasthenia gravis;
- hypersensitivity.
Co-administration of phenobarbital with the combination of nirmatrelvir + ritonavir is also a strict contraindication due to drug interactions.
What clinical symptoms are characteristic of acute barbiturate poisoning?
Mild barbiturate intoxication is characterized by drowsiness, ataxia, slurred speech, tachycardia, miosis, and shallow breathing. Severe intoxication may present with coma, loss of pupillary light reflex, respiratory depression including pulmonary edema, mechanical asphyxiation and secondary pneumonia, as well as cardiac dysfunction. Loss of the pharyngeal reflex increases the likelihood of aspiration.
How exactly does phenobarbital alter the physiological sleep architecture?
Phenobarbital, as a barbituric acid derivative, markedly disrupts the physiological sleep architecture by altering the ratio of rapid (REM) and non-rapid eye movement (NREM) sleep phases. In contrast, zolpidem and zopiclone have a minimal impact on sleep architecture.
The concentration of which drug groups is clinically significantly reduced by phenobarbital when co-administered?
Phenobarbital is a potent inducer of hepatic microsomal enzymes and accelerates the metabolism of other drugs. The efficacy of oral contraceptives is clinically significantly reduced due to accelerated estrogen metabolism and decreased contraceptive effectiveness. The metabolism of digitoxin is also accelerated.
To remember the difference: PHEnobarbital = FUndamental and long-acting (8 hours, epilepsy, accumulation). CYclobarbital = CYcle of sleep (shorter, 5–6 hours, less hangover effect).
Class and exam questions
Why is phenobarbital limited in its use as a hypnotic?
It disrupts the physiological sleep architecture, causes a severe hangover effect (morning grogginess, somnolence), and rapidly leads to tolerance and dependence.
What is autoinduction using the example of phenobarbital?
Autoinduction is a process in which phenobarbital, being a potent inducer of hepatic microsomal enzymes, stimulates the production of enzymes that accelerate its own breakdown and elimination.
What is the main pharmacokinetic difference between phenobarbital and cyclobarbital?
The difference lies in the duration of action: phenobarbital has a long duration of action (about 8 hours) and tends to accumulate, whereas cyclobarbital works for 5–6 hours and causes a less pronounced hangover effect.
What else to study on this topic
- Mechanism of changes in the physiological structure of sleep under the influence of barbiturates
- Pathogenesis of drug dependence development on barbituric acid derivatives
- Interaction of phenobarbital with other drugs at the level of hepatic enzymes
- Specifics of using barbiturates as part of combination drugs (Valocordin, Reladorm)
Master the entire topic in the «Pharmacology» course
This is a summary. The course covers everything tested in classes and exams.
- Complete study guide on "Phenobarbital and Cyclobarbital" and 5,304 other pages of the subject
- Assignments and quizzes after every topic — just like in a colloquium
- AI tutor answers questions on the topic anytime
- 116 video lessons on the subject
Other topics in the section "Agents Used in Psychiatry and Neurology"
Free video lessons: pharmacologyShort lessons with study notes — no registration required.
Prepared by WhiteCoat Pro faculty in accordance with the medical school curriculum. For educational purposes only.